CoChat

Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non‐small cell lung cancer

Open access
Saleem, Wael, Suzuki, Yoshiyuki, Mobaraki, Abdulelah, Yoshida, Yukari, Noda, Shinei, Saitoh, Jun‐ich, Nakano, Takashi · 2011 · Cancer Science
Cited by 34

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (E‐TKI) resistance has emerged as an important clinical issue. To overcome this resistance, researchers have examined different modalities, either for use as a monotherapy or in combination with E‐TKI therapy. In the present study, we investigated whether a decrease in nitric oxide (NO) levels affects the radiosensitization of non‐small cell lung cancer (NSCLC) cell lines. A549 and H3255 NSCLC cells were examined. They were subjected to hypoxic conditions and monotherapy, or combined therapy using radiation and NG‐monomethyl‐l‐arginine, monoacetate (LNMMA). Reductions in nitric oxide levels enhanced the radiosensitivity of both cell lines and significantly reduced the expression of both hypoxia‐inducible factor‐1α (HIF‐1α) and EGFR in H3255 cells compared to A549 cells. Since NO is significantly associated with cell metabolism, we measured the levels of pyruvate dehydrogenase kinase‐1 (PDK‐1), reactive oxygen species, and oxygen and observed that the expression of PDK‐1 was significantly reduced. This reduction was seen simultaneously after the silencing of HIF‐1α; however, not following LNMMA treatment. The oxygen concentration was significantly increased in the treated cells, and their viability decreased in parallel. Reactive oxygen species were decreased after LNMMA and radiation treatment. Adding EGFR–TKI to cells with reduced NO levels further suppressed cell viability when combined with radiation. This study suggests that a reduction in the NO level might substantially overcome the radioresistance of mutant NSCLC cells. (Cancer Sci 2011; 102: 2150–2156)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1349-7006.2011.02095.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 34

Metadata

Authors
Saleem, W., Suzuki, Y., Mobaraki, A., Yoshida, Y., Noda, S., Saitoh, J., & Nakano, T.
Venue
Cancer Science
Publisher
Wiley
Published
2011-10-12
Volume
102
Issue
12
Pages
2150-2156
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W1965359368
Cited by
34
References
7
FWCI
0.69
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non‐small cell lung cancer. https://app.cochat.ai/papers/10.1111/j.1349-7006.2011.02095.x
The paper
Saleem, W., Suzuki, Y., Mobaraki, A., Yoshida, Y., Noda, S., Saitoh, J., & Nakano, T. (2011). Reduction of nitric oxide level enhances the radiosensitivity of hypoxic non‐small cell lung cancer. Cancer Science. https://doi.org/10.1111/j.1349-7006.2011.02095.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.